Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. SC 13D Stake Beneficial Ownership Report
  2. 8-K Event Regulation FD disclosure
  3. D Other Notice of Sales of Unregistered Securities
  4. 8-K Event Material agreement
  5. 424B5 Offering Prospectus
  6. 10-Q Report Quarterly Report
  7. 8-K Event Regulation FD disclosure
  8. 8-K Event Regulation FD disclosure
  9. 8-K Event Regulation FD disclosure
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 8-K Event Regulation FD disclosure
  12. 10-Q Report Quarterly Report
  13. 8-K Event Regulation FD disclosure
  14. 10-K Report Annual Report
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 8-K Event Regulation FD disclosure
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 8-K Event Regulation FD disclosure
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 8-K Event Regulation FD disclosure

Page 10 of 31 · 604 filings